Home > Boards > US Listed > Biotechs >

Midatech (MTP)

MTP RSS Feed
Add MTP Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 5/21/2019 9:23:34 AM - Followers: 19 - Board type: Free - Posts Today: 0





5 Marketed Products + Oral thin-film Insulin with P2 Results in April which has Multiple Blockbuster Potential and many other drugs in clinical Trials . this undiscovered low float stock is brutally undervalued alone the marketed drugs will drive this Company into profitability within 2 years . If the Phase 2 results of the Oral Insulin in April is positive then this low float stock could explode like Oramed (ORMP) did in end 2013 to early 2014 which send the stock from $10 to almost $30 within days .

This Undiscovered Stock with a Market Cap of less than $60 Million and over $30 Million in Cash is heavily underpriced but this will Change very soon especially when the Outcome of the Oral Insulin is positive .GL



Midatech Pharma (MTP)

Market Cap: $59.5 Million
Cash: $35 Million
Price: $3.58

Shares Out: 16.6 Million


MidatechPharma US: Focus On Oncology and Supportive Care:

Zuplenz: Oral film for Chemo/Radio Rx Induced Nausea & Vomiting Highly effective 5HT3 antagonist Launch H1 2016

Gelclair: Hyaluronic Acid Oral Gel For Oral Mucositis 85-100% of H&N cancer patients on chemo/radiotherapy develop OM Leads market in US strong growth expected 2016

Aquoral:Oral Spray Treatment For Dry Mouth Xerostomia

Oravig:Buccal Tablet For Oral Candidiasis In Adults Serious complication for patients undergoing radio/chemotherapy Launched H2 2015 –first full year of sales 2016

Ferralet90: Dual Iron Delivery Anaemia treatment


Oral thin-film Insulin:

From positive Phase I clinical trial results it has been demonstrated that the transbuccal insulin formulation is safe and well tolerated in healthy human volunteers and that it is absorbed faster and utilised more quickly than subcutaneous insulin.

•Phase I (2012) -No safety concerns
-Suggests insulin enters blood, faster to max effect

•Phase IIa-Completed in life phase January 2016
-Clinical Study Report is expected in April 2016

•Phase II data will inform strategic opportunities (license or exit)

“Diabetes incidence is forecast to hit 500m people, globally, by 2025; with our partnered transbuccal insulin strip, MSL-001 is targeting a $20 billion market, adding significant revenue potential to our growing portfolio of products.”



Jim Phillips Presents on behalf of Midatech Pharma at the Biotech Capital Conference
https://www.youtube.com/watch?v=GrrfbLeJWpU



March Presentation
http://www.midatechpharma.com/uploads/Midatech%20Deck%202016%20march%2003%20Com.pdf



Major shareholders
http://www.midatechpharma.com/investors/share-information.html



Edison Research
http://www.edisoninvestmentresearch.com/research/report/midatech4/preview/

Valuation: Increased to $221.0m from $200.7m

Our valuation for Midatech increases to $221.0m from $200.7m previously (or $13.29/ADR from $14.45/ADR, as we now incorporate the acquisitions of DARA and Zuplenz. Our valuation for DARA is based on forecast future operating cash flows (excluding potential payments on contingent value rights that are dependent on sales milestones, which exceed our relatively conservative projections). Additionally, we adjust our valuation for Midatech upward as our model has been rolled forward by six months and rebased to 2016.







MTP
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MTP News: Specialized Disclosure Report (sd) 05/14/2019 04:01:39 PM
MTP News: Annual and Transition Report (foreign Private Issuer) (20-f) 04/30/2019 04:28:38 PM
MTP News: Report of Foreign Issuer (6-k) 04/26/2019 09:35:12 AM
MTP News: Report of Foreign Issuer (6-k) 04/24/2019 06:07:33 AM
MTP News: Post-effective Amendment to a Previously Filed F-6. (f-6 Pos) 04/08/2019 05:25:33 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#475   No posts in 3 weeks waytoorandom 05/21/19 09:23:34 AM
#474   Market cap today is about $42MM, which isn't tykundegex 05/03/19 11:54:25 AM
#473   Well, I guess he created a buying opportunity. scotsand 05/03/19 11:42:21 AM
#472   He’s a shorter. That’s why this tumbled so waytoorandom 05/03/19 11:37:54 AM
#471   Bought more. Big potential....market cap wrong on scotsand 05/03/19 11:00:22 AM
#470   Touche scotsand 05/03/19 08:47:10 AM
#469   You cared enough to respond. ClayTrader 05/03/19 08:46:31 AM
#468   Nobody cares scotsand 05/03/19 08:46:05 AM
#467   Why are we down 50% from last weeks highs? waytoorandom 04/30/19 05:01:46 PM
#466   Clay was here with his “charts” In my experience waytoorandom 04/26/19 08:46:05 AM
#465   yep, still holding wesley_ 04/26/19 01:44:29 AM
#464   Grossly undervalued here waytoorandom 04/25/19 11:45:13 AM
#463   Should be at $3.00 based on 11.5 pence waytoorandom 04/24/19 09:59:52 PM
#462   * * $MTP Video Chart 04-24-2019 * * ClayTrader 04/24/19 04:39:29 PM
#461   Looks like you may get a bounce here BillG2436 04/24/19 03:08:38 PM
#460   I made a quick $140 off this stock Go_Getter 04/24/19 12:51:19 PM
#459   Vicious pull back Not sure why. Revs increase 96% waytoorandom 04/24/19 12:44:25 PM
#458   loading some below 3.00 :) wesley_ 04/24/19 12:37:33 PM
#457   Up 70% overseas waytoorandom 04/24/19 10:17:34 AM
#456   A low float will frequently have that effect..... davidsson10 04/24/19 09:52:41 AM
#455   It looks like somebody is literally buying all waytoorandom 04/24/19 09:48:43 AM
#454   50% up. Moves like butter scotsand 04/24/19 09:40:35 AM
#453   http://www.midatechpharma.com/news/37/86/Financial-results-for-year-ended-31-Dec davidsson10 04/24/19 09:29:46 AM
#452   Looks like 2018 financials out. I havent scotsand 04/24/19 07:48:45 AM
#451   12 days no posts...magnificent waytoorandom 04/22/19 03:55:01 PM
#450   The market cap of the actual stock trading scotsand 04/10/19 06:55:50 PM
#449   https://register.epo.org/application?number=EP16812959 waytoorandom 04/10/19 10:49:46 AM
#448   It’s fun to watch the level 2 on this waytoorandom 04/10/19 10:43:39 AM
#447   Ultimately no reverse split since ratio changed. scotsand 04/08/19 08:28:25 PM
#446   True, should equal 20 shares which doesnt make scotsand 04/08/19 04:58:11 PM
#445   How does diluting an ADR work? Doesn’t it waytoorandom 04/08/19 04:55:35 PM
#444   Unless dilution since early March for ADR. scotsand 04/08/19 03:45:22 PM
#443   I mean whole float changed hands waytoorandom 04/08/19 03:43:17 PM
#442   How can there only be 800k float when waytoorandom 04/08/19 03:42:54 PM
#441   This seems extremely positive—-each ADR is worth 20 scotsand 04/08/19 03:13:04 PM
#440   I missed it,what happened ? Was there GrabThatCash 04/08/19 02:15:01 PM
#439   Yes. Except OS also updates from 40million to 200million waytoorandom 04/08/19 11:35:33 AM
#438   Yup looks like it mylar23 04/08/19 11:23:09 AM
#437   RS ??? THE LOG 04/08/19 10:19:55 AM
#436   We are about to witness some pretty strange waytoorandom 04/08/19 09:28:49 AM
#435   Is it just me or did the OS waytoorandom 04/08/19 07:28:31 AM
#434   I got lucky for once and bought at scotsand 04/05/19 12:29:07 PM
#433   I keep adding these dips... waytoorandom 04/05/19 12:26:38 PM
#432   True.. scotsand 04/05/19 12:25:37 PM
#431   Why would a billionaire need to dilute his waytoorandom 04/05/19 12:11:50 PM
#430   May be a good one to jump into scotsand 04/05/19 12:00:00 PM
#429   ARCX and NSDQ working together to walk it waytoorandom 04/05/19 09:32:39 AM
#428   Up 22% overseas waytoorandom 04/05/19 08:30:48 AM
#427   I wasn’t lying: http://secfilings.nasdaq.com/filingFrameset.asp?FilingID=133098 waytoorandom 04/04/19 05:28:32 PM
#426   I saw u post r/s I panic sold JusDePomme 04/04/19 05:17:39 PM
PostSubject